Metformin protects cells from mutant huntingtin toxicity through activation of AMPK and modulation of mitochondrial dynamics

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055 · see citing works

Metformin improves healthspan and lifespan in mice

Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3192 · Cited by 1,445 · see citing works

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885 · see citing works

Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity

Song, W., Chen, J., Petrilli, A. M., Liot, G., Klinglmayr, E., Zhou, Y., Poquiz, P., Tjong, J., Pouladi, M. A., Hayden, M. R., et al. (2011) · Nature Medicine · doi:10.1038/nm.2313 · Cited by 556 · see citing works

Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation

Wang, J., Gallagher, D., DeVito, L. M., Cancino, G. I., Tsui, D., He, L., Keller, G. M., Frankland, P. W., Kaplan, D. R., & Miller, F. D. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.016 · Cited by 474 · see citing works

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice

Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X.-J., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536856100 · Cited by 428 · see citing works

Calorie restriction mimetics: an emerging research field

Ingram, D. K., Zhu, M., Mamczarz, J., Zou, S., Lane, M. A., Roth, G. S., & de Cabo, R. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00202.x · Cited by 415 · see citing works

Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide

Łabuzek, K., Suchy, D., Gabryel, B., Bielecka, A., Liber, S., & Okopień, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70357-1 · Cited by 405 · see citing works

Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease

Shirendeb, U. P., Calkins, M. J., Mańczak, M., Anekonda, V., Dufour, B. D., McBride, J. L., Mao, P., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr475 · Cited by 383 · see citing works

Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease

Kim, J., Moody, J. P., Edgerly, C. K., Bordiuk, O. L., Cormier, K., Smith, K., Beal, M. F., & Ferrante, R. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq306 · Cited by 356 · see citing works

A structural view of mitochondria-mediated apoptosis.

Shi, Y. (2001) · Nature Structural Biology · doi:10.1038/87548 · Cited by 307 · see citing works

Coordinated time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy controls osteogenic differentiation of human mesenchymal stem cells

Pantovic, A., Krstić, J., Janjetović, K., Kocić, J., Harhaji-Trajkovic, L. M., Bugarski, D. S., & Trajković, V. (2012) · Bone · doi:10.1016/j.bone.2012.10.024 · Cited by 263 · see citing works

Mitochondrial Respiration and ATP Production Are Significantly Impaired in Striatal Cells Expressing Mutant Huntingtin

Milakovic, T., & Johnson, G. V. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504749200 · Cited by 259 · see citing works

Effects of overexpression of Huntingtin proteins on mitochondrial integrity

Wang, H., Lim, P. J., Karbowski, M., & Monteiro, M. J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn404 · Cited by 222 · see citing works

Metformin therapy in a transgenic mouse model of Huntington's disease

Ma, T. C., Buescher, J. L., Oatis, B., Funk, J. A., Nash, A. J., Carrier, R. L., & Hoyt, K. R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.039 · Cited by 220 · see citing works

Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease

Ju, T., Chen, H., Lin, J., Chang, C., Chang, W.-C., Kang, J.-J., Sun, C., Tao, M., Tu, P., Chang, C., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201105010 · Cited by 183 · see citing works

Regulation of mitochondrial fission and apoptosis by the mitochondrial outer membrane protein hFis1

Yu, T., Fox, R. J., Burwell, L. S., & Yoon, Y. (2005) · Journal of Cell Science · doi:10.1242/jcs.02537 · Cited by 172 · see citing works

Trinucleotide repeat length and clinical progression in Huntington's disease

Brandt, J., Bylsma, F., Gross, R., Stine, O. C., Ranen, N. G., & Ross, C. A. (1996) · Neurology · doi:10.1212/wnl.46.2.527 · Cited by 155 · see citing works

An anti-aging drug today: from senescence-promoting genes to anti-aging pill

Blagosklonny, M. V. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.01.004 · Cited by 148 · see citing works

Mitochondrial function and parental sex effect in Huntington's disease

Mann, V. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)92242-a · Cited by 146 · see citing works

The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro

Dulović, M., Jovanović, M., Xilouri, M., Stefanis, L., Harhaji-Trajkovic, L. M., Kravic‐Stevovic, T., Paunović, V., Ardah, M. T., El‐Agnaf, O. M. A., Kostić, V., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.002 · Cited by 123 · see citing works

Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission

Reddy, P. H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.020 · Cited by 106 · see citing works

Impaired Mitochondrial Dynamics and Nrf2 Signaling Contribute to Compromised Responses to Oxidative Stress in Striatal Cells Expressing Full-Length Mutant Huntingtin

Jin, Y. N., Yu, Y. V., Gundemir, S., Jo, C., Cui, M., Tieu, K., & Johnson, G. V. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057932 · Cited by 102 · see citing works

Mitochondrial membrane dynamics, cristae remodelling and apoptosis

Heath-Engel, H. M., & Shore, G. C. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.02.006 · Cited by 101 · see citing works

Huntington's disease, calcium, and mitochondria

Giacomello, M., Hudec, R., & Lopreiato, R. (2011) · BioFactors · doi:10.1002/biof.162 · Cited by 47 · see citing works

AMP‐activated protein kinase counteracts brain‐derived neurotrophic factor‐induced mammalian target of rapamycin complex 1 signaling in neurons

Ishizuka, Y., Kakiya, N., Witters, L. A., Oshiro, N., Shirao, T., Nawa, H., & Takei, N. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12362 · Cited by 45 · see citing works

AMPK protects proximal tubular cells from stress-induced apoptosis by an ATP-independent mechanism: potential role of Akt activation

Lieberthal, W., Zhang, L., Patel, V. A., & Levine, J. S. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00034.2011 · Cited by 37 · see citing works

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.

Ravn, P., Haugen, A. G., & Glintborg, D. (2013) · PubMed · Cited by 29 · see citing works

Metformin ameliorates core deficits in a mouse model of fragile X syndrome

Gantois, I., Khoutorsky, A., Popić, J., Aguilar‐Valles, A., Freemantle, E., Cao, R., Sharma, V. K., Pooters, T., Nagpal, A., Skalecka, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4335 · Cited by 228 · see citing works

Causal roles of mitochondrial dynamics in longevity and healthy aging

Sharma, A., Smith, H. J., Yao, P., & Mair, W. B. (2019) · EMBO Reports · doi:10.15252/embr.201948395 · Cited by 214 · see citing works

Metformin reverses early cortical network dysfunction and behavior changes in Huntington’s disease

Arnoux, I., Willam, M., Griesche, N., Krummeich, J., Watari, H., Offermann, N., Weber, S. S., Dey, P. N., Chen, C., Monteiro, O., et al. (2018) · eLife · doi:10.7554/elife.38744 · Cited by 117 · see citing works

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities

Harding, R., & Tong, Y. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.11 · Cited by 111 · see citing works

Mitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity

López-Lluch, G. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.12.005 · Cited by 103 · see citing works

Mitochondrial Transfer as a Novel Therapeutic Approach in Disease Diagnosis and Treatment

Clemente‐Suárez, V. J., Martín-Rodríguez, A., Sepulveda, R. A. Y., & Tornero-Aguilera, J. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108848 · Cited by 94 · see citing works

Metabolic Aspects of Adenosine Functions in the Brain

Garcia‐Gil, M., Camici, M., Allegrini, S., Pesi, R., & Tozzi, M. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.672182 · Cited by 86 · see citing works

Metabolic Profiles Associated With Metformin Efficacy in Cancer

Andrzejewski, S., Siegel, P. M., & St‐Pierre, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00372 · Cited by 83 · see citing works

Mitochondrial Dysfunction in Age‐Related Metabolic Disorders

Natarajan, V., Chawla, R., Mah, T. K. L., Vivekanandan, R., Tan, S., Sato, P. Y., & Mallilankaraman, K. B. (2020) · PROTEOMICS · doi:10.1002/pmic.201800404 · Cited by 81 · see citing works

Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases

Du, M., Gao, Q.-Y., Liu, C., Bai, L.-Y., Li, T. X., & Wei, F. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.838173 · Cited by 79 · see citing works

Metformin Improves Neurologic Outcome Via AMP‐Activated Protein Kinase–Mediated Autophagy Activation in a Rat Model of Cardiac Arrest and Resuscitation

Zhu, J., Liu, K., Huang, K., Gu, Y., Hu, Y., Pan, S., & Ji, Z. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008389 · Cited by 66 · see citing works

Increased translation as a novel pathogenic mechanism in Huntington’s disease

Creus‐Muncunill, J., Badillos-Rodríguez, R., García-Forn, M., Masana, M., Barriga, G. G.-D., Guisado-Corcoll, A., Alberch, J., Malagelada, C., Delgado-Garcia, J. M., Gruart, A., et al. (2019) · Brain · doi:10.1093/brain/awz230 · Cited by 58 · see citing works

AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases

Qin, S., Tang, H., Li, W., Gong, Y., Li, S., Huang, J., Fang, Y., Yuan, W., Liu, Y., Wang, S., et al. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200523172334 · Cited by 53 · see citing works

Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease

Pircs, K., Drouin‐Ouellet, J., Horváth, V., Gil, J., Rezeli, M., Garza, R., Grassi, D. A., Sharma, Y., St‐Amour, I., Harris, K. L., et al. (2021) · Brain · doi:10.1093/brain/awab473 · Cited by 53 · see citing works

Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity

Arbez, N., Ratovitski, T., Roby, E., Chighladze, E., Stewart, J. C., Ren, M., Wang, X., Lavery, D. J., & Ross, C. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.782300 · Cited by 52 · see citing works

Promising use of metformin in treating neurological disorders: biomarker-guided therapies

Loan, A., Syal, C., Lui, M., He, L., & Wang, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385286 · Cited by 49 · see citing works

Overview of Metformin and Neurodegeneration: A Comprehensive Review

Kruczkowska, W., Gałęziewska, J., Buczek, P., Płuciennik, E., Kciuk, M., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18040486 · Cited by 50 · see citing works

Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease

Fão, L., & Rego, A. C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8004 · Cited by 37 · see citing works

Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders

Soo, S. K., Rudich, P. D., Traa, A., Harris-Gauthier, N., Shields, H. J., & Raamsdonk, J. M. V. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111297 · Cited by 37 · see citing works

Does calorie restriction improve cognition?

Dias, I. R., SANTOS, C. D. S., Magalhães, C. O. D. E., de Oliveira, L. R. S., Dias‐Peixoto, M. F., Sousa, R. A. L. D., & Cassilhas, R. C. (2020) · IBRO Reports · doi:10.1016/j.ibror.2020.05.001 · Cited by 32 · see citing works

Boosting mitochondrial health to counteract neurodegeneration

Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 34 · see citing works

Resveratrol suppresses bone cancer pain in rats by attenuating inflammatory responses through the AMPK/Drp1 signaling

Hao, M., Tang, Q., Wang, B., Li, Y., Ding, J., Li, M., Xie, M., & Zhu, H. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz162 · Cited by 31 · see citing works

Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions

Magalhães, J. D., Fão, L., Vilaça, R., Cardoso, S. M., & Rego, A. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111625 · Cited by 27 · see citing works

The neurobiology of the Prader-Willi phenotype of fragile X syndrome

Muzar, Z., Lozano, R., Kolevzon, A. L., & Hagerman, R. J. (2016) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2016.01082 · Cited by 22 · see citing works

Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics

Pérez-Arancibia, R., Cisternas-Olmedo, M., Sepúlveda, D., Troncoso-Escudero, P., & Vidal, R. L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1084493 · Cited by 20 · see citing works

Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder

Trujillo-Del Río, C., Tortajada-Pérez, J., Gómez-Escribano, A. P., Casterá, F., Peiró, C., Millán, J. M., Herrero, M. J., & Vázquez-Manrique, R. P. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111670 · Cited by 19 · see citing works

Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington’s disease

Jiang, M., Zhang, X., Liu, H., LeBron, J., Alexandris, A., Peng, Q., Gu, H., Yang, F., Li, Y., Wang, R., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa061 · Cited by 15 · see citing works

Metformin improves depressive-like behavior in experimental Parkinson’s disease by inducing autophagy in the substantia nigra and hippocampus

Mendonça, I. P., de Paiva, I. H. R., Duarte-Silva, E. P., de Melo, M. G., da Silva, R. S., do Nascimento, M. I. X., & Peixoto, C. A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01043-6 · Cited by 17 · see citing works

Could metformin be therapeutically useful in Huntington’s disease?

Tang, B. L. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0072 · Cited by 15 · see citing works

Potential Benefits of Combined Statin and Metformin Therapy on Resistance Training Response in Older Individuals

Long, D. E., Kosmac, K., Dungan, C. M., Bamman, M. M., Peterson, C. A., & Kern, P. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.872745 · Cited by 14 · see citing works

Metformin Protects Myelin from Degeneration in A Mouse Model of Iysophosphatidylcholine-Induced Demyelination in The Optic Chiasm.

Esmaeilnejad, S., Semnanian, S., & Javan, M. (2021) · PubMed Central · doi:10.22074/cellj.2021.7174 · Cited by 12 · see citing works

Cellular stress and AMPK links metformin and diverse compounds with accelerated emergence from anesthesia and potential recovery from disorders of consciousness

Finley, J. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.01.014 · Cited by 10 · see citing works

Postnatal Dexamethasone Therapy Impairs Brown Adipose Tissue Thermogenesis and Autophagy Flux in Neonatal Rat Pups

Chang, Y.-S., Hou, S.-Y., Yu, S.-S., Tsai, S.-Y., Chen, Y., Hsu, L., Tsai, P.-J., Lin, H., Lin, C.-H., & Tsai, Y.-S. (2022) · Theranostics · doi:10.7150/thno.70752 · Cited by 10 · see citing works

An integrative neuropharmacological review of Huntington’s disease challenges and the role of novel formulations in addressing pharmacological‒pharmaceutical limitations

Senousy, M. A., Eid, A. H., Zaki, M. B., Abd‐Elmawla, M. A., Ghaiad, H. R., El‐Shiekh, R. A., Ahmed, S., & Khalifa, H. O. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1794983 · Cited by 9 · see citing works

Highlighting the Protective or Degenerative Role of AMPK Activators in Dementia Experimental Models

Nikbakhtzadeh, M., Shaerzadeh, F., & Ashabi, G. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210526160214 · Cited by 9 · see citing works

Berberine can be a Potential Therapeutic Agent in Treatment of Huntington's Disease: A Proposed Mechanistic Insight

Sharma, S., Kaur, I., Dubey, N., Goswami, N., & Tanwar, S. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05054-6 · Cited by 8 · see citing works

Metformin Reduces Repeat Mild Concussive Injury Pathophysiology

Underwood, E. L., Redell, J. B., Maynard, M. E., Kobori, N., Hylin, M. J., Hood, K. N., West, R. K., Zhao, J., Moore, A. N., & Dash, P. K. (2021) · eNeuro · doi:10.1523/eneuro.0421-21.2021 · Cited by 6 · see citing works

Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington’s Disease

Paré, M., & Jasmin, B. J. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00516 · Cited by 4 · see citing works

Regulation of Mutant Huntingtin Mitochondrial Toxicity by Phosphomimetic Mutations within Its N-Terminal Region

Yablonska, S., Strohlein, C. E., Баранов, В. С., Yeh, S. M., Patel, A., Singh, T., Jauhari, A., Kim, J., Khattar, N. K., Li, F., et al. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1254-24.2024 · Cited by 3 · see citing works

Distinct sub-cellular autophagy impairments occur independently of protein aggregation in induced neurons from patients with Huntington’s diseasePreprint

Pircs, K., Drouin‐Ouellet, J., Gil, J., Rezeli, M., Grassi, D. A., Garza, R., Sharma, Y., St‐Amour, I., Jönsson, M. E., Johansson, P. A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.01.433433 · Cited by 3 · see citing works

Phytotherapeutic targeting of the mitochondria in neurodegenerative disorders

Sarkar, P., Kumar, A. A., Behera, P. S., & Thirumurugan, K. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.013 · Cited by 2 · see citing works

Mechanism and Clinical Application Prospects of Mitochondrial DNA Single Nucleotide Polymorphism in Neurodegenerative Diseases

Xu, M., Li, T., Liu, X., Islam, B., Xiang, Y., Zou, X., & Wang, J. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04311-9 · Cited by 2 · see citing works

Molecular Mechanisms of the Effects of Metformin on the Functional Activity of Brain Neurons

Shpakov, A. O., & Derkach, K. V. (2018) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-018-0657-6 · Cited by 2 · see citing works

Role of AMPK in aging and age-related loss of behavioral plasticity in C. elegans

Escoubas, C. C. (2018) · HAL · doi:10.70675/1c8dd62ez2561z4581zaa55z169311331b91 · Cited by 2 · see citing works

Metformin restores mitochondrial bioenergetics and redox homeostasis through modulation of mitochondrial biogenesis and dynamics in patient derived cultured fibroblasts and an animal model of molybdenum cofactor deficiency

Brondani, M., Ribeiro, R. T., Pinheiro, C. V., Hoffmann, C. I. H., Marcuzzo, M. B., Mohsen, A.-W. A., Wajner, M., Seminotti, B., Vockley, J. E., & Leipnitz, G. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118123 · Cited by 1 · see citing works

RNA-Binding Proteins and Translation in Neurodegenerative Disease

Duncan, K. E. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190686307.013.25

Proteostasis in Huntington’s Disease: Disease Mechanisms and Therapeutic OpportunitiesPreprint

Harding, R., & Tong, Y. (2018) · Preprints.org · doi:10.20944/preprints201801.0179.v1

Repeat-associated non-AUG (RAN) translation and Huntington's disease: Pathology, mechanistic and therapeutic perspectives

Báñez-Coronel, M., Cleary, J. D., & Ranum, L. P. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00011-x

Role of microbiota-gut-brain axis in Huntington’s disease and possible interventions

Kumar, S., & Yadav, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00004-3 · Cited by 1 · see citing works

Effect of chronic metformin treatment in a mouse model of Huntington's disease

Adhihetty, P. J., Iorio, L., Hennessy, T., Ho, D. J., Calingasan, N. Y., Yang, W. X., & Beal, F. M. (2010) · The FASEB Journal · doi:10.1096/fasebj.24.1_supplement.lb683

AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease

Vázquez‐Manrique, R. P., Farina, F., Cambon, K., Sequedo, M. D., Parker, J. A., Millán, J. M., Weiss, A., Déglon, N., & Néri, C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv513 · Cited by 112 · see citing works

A09 Characterisation of AMPK activity in models of Huntington's disease pathogenesis

Vázquez‐Manrique, R. P., Cambon, K., Offner, N., Darbois, A., Orfila, A.-M., Déglon, N., & Néri, C. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.222570.9

Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder

Trujillo-Del Río, C., Tortajada-Pérez, J., Gómez-Escribano, A. P., Casterá, F., Peiró, C., Millán, J. M., Herrero, M. J., & Vázquez-Manrique, R. P. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111670 · Cited by 19 · see citing works

Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease

Sanchís, A., García-Gimeno, M. A., Martínez, A. J. C., Sequedo, M. D., Millán, J. M., Sanz, P., & Vázquez‐Manrique, R. P. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0264-9 · Cited by 89 · see citing works